Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector.

Hematopoietic stem cell gene therapy requires the use of integrating retroviral vectors in order to stably transmit a therapeutic gene to mature blood cells. Human clinical trials have shown that some vector integration events lead to disrupted regulation of proto-oncogenes resulting in disordered h...

Full description

Bibliographic Details
Main Authors: Sheng Zhou, Zhijun Ma, Taihe Lu, Laura Janke, John T Gray, Brian P Sorrentino
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3633865?pdf=render

Similar Items